Your session is about to expire
← Back to Search
Bulking Agent
Macroplastique for Stress Incontinence (ROSE Trial)
N/A
Waitlist Available
Research Sponsored by Uroplasty, Inc
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 5-years
Awards & highlights
ROSE Trial Summary
This study is evaluating whether a surgery to tighten the muscles around the urethra can help women with stress urinary incontinence.
Eligible Conditions
- Stress Incontinence
ROSE Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 5-years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~5-years
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
To describe the incidence of additional or alternative treatment for stress urinary incontinence due to ISD following up to two Macroplastique treatments over a 5 year period.
Secondary outcome measures
To describe the incidence of genitourinary and treatment related adverse events, including transient symptoms associated with the injection procedure.
ROSE Trial Design
1Treatment groups
Experimental Treatment
Group I: MacroplastiqueExperimental Treatment1 Intervention
Macroplastique will be used for the treatment in an open-label, five year, post-market study
Find a Location
Who is running the clinical trial?
Uroplasty, IncLead Sponsor
5 Previous Clinical Trials
466 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger